Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Eating a balanced diet with the right vitamins and minerals is important for healthy hair, but too many supplements can be harmful.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Skin issues can indicate immune system problems.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Topical tofacitinib is effective and safe for treating alopecia areata.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

A vitamin D receptor mutation causes rickets and affects immune responses.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.